|Application:||Gene expression microarray analysis|
|Number of samples:||12|
|Release date:||Dec 19 2009|
|Last update date:||Apr 5 2017|
|Diseases:||Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive|
|Dataset link||Imatinib and Nilotinib induced molecular changes in Philadelphia chromosome-positive Chronic Myelogenous Leukemia|
Affymetrix U133A 2.0 microarrays were used to examine the gene expression profile of K562 cells after in vitro treatment with Imatinib (0.5 µM) or Nilotinib (0.05 µM) for 24 hours. Gene expression data of the treated cells were compared with data of untreated cells.